We found that the sclerostin levels were higher in OI patients than in control individuals, but Palomo et al. [8] and Brunetti et al. [9] reported that the sclerostin levels of OI patients were similar to those of healthy control individuals (sample sizes: n = 76 and 18, respectively). Here, SOST is linked to osteogenesis imperfecta.